Chicago, IL (PRWEB) April 10, 2006
Carematix, the leading provider of wireless telehealth monitors, has joined forces with the University of Pennsylvania School of Nursing to conduct a four-year study on the effectiveness of telehome monitoring. The study is funded by a grant for more than $1 million from the National Institute of Nursing Research.
The study, led by Dr. Kathryn Bowles, associate professor of nursing at the University of Pennsylvania School of Nursing, Philadelphia, will attempt to demonstrate that telehomecare improves patient self care, quality of life and satisfaction while reducing hospitalizations and costs.
Beginning today, Bowles and her interdisciplinary team of researchers will track 216 patients, ages 55 and older, with congestive heart failure over the next four years. Half of the patients will receive Carematix wireless monitors, including weight scales, blood pressure monitors, pulse oximeters and glucometers, while the remainder of patients will continue to be administered with home nursing care. Every few months, researchers will collect data about the patients’ overall wellness and care-providing experience.
“Telehome care is a promising technology to help chronically ill patients monitor their wellness and ensure they are receiving proper care in a cost-effective manner,” said Bowles, a registered nurse for 28 years.
According to Carematix Founder and CEO Sukhwant Khanuja, the company is thrilled to be the benchmark for a study with such profound implications.
“Our wireless solutions are being widely embraced by hospitals and homecare organizations as a more natural and cost effective alternative to wired, remote patient-monitoring stations,” he said. “At Carematix, our primary mission is to improve outcomes by constantly inventing solutions that enhance the data accuracy and patient experience in wellness monitoring. We are pleased to have been selected to partner with the University of Pennsylvania School of Nursing in this landmark study. What’s more, we are delighted to work with Dr. Bowles, given her wealth of knowledge and renowned reputation in the field.”
Carematix wireless monitors will be used for the study. These monitors allow patients to take readings from anywhere in their home, as the captured data is automatically transmitted to the health care professional via phone lines and the Internet. Nurses are automatically alerted if readings or trends are outside pre-established norms. For more information about the study, visit the University of Pennsylvania School of Nursing website at http://www.nursing.upenn.edu.
Chicago-based Carematix is the first and largest telehealth monitoring company to use wireless technology to improve the patient experience, which results in the highest level of patient self-compliance. Carematix introduced the first glucose monitor that wirelessly and automatically sends readings to the caregiver. Today, the company offers a wide range of wireless monitors, including weight scales, pulse oximeters, glycometers and blood pressure units.
The Carematix solution effectively helps care-giving organizations reduce patient hospitalizations, lower healthcare costs, and improve patient outcomes by achieving the highest patient satisfaction rates and delivering the most accurate and actionable data. Carematix customers include care management organizations, disease management firms, self-insured employers and home healthcare agencies.
# # #